Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.61 |
| ▸ | SLC6A2 | P23975 | 12/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 12/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 12/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL477559 | 1.00 | UGT2B7 (0.61) | UGT2B7SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL30161628 | 1.00 | UGT2B7 (0.61) | UGT2B7SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL12405817 | 0.94 | UGT2B7 (0.53) | UGT2B7SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL30033673 | 0.93 | UGT2B7 (0.68) | UGT2B7SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL600527 | 0.93 | UGT2B7 (0.68) | UGT2B7SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL26326669 | 0.90 | UGT2B7 (0.55) | UGT2B7SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL26326655 | 0.86 | UGT2B7 (0.55) | UGT2B7SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL14033733 | 0.86 | UGT2B7 (0.55) | UGT2B7SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL26326654 | 0.86 | UGT2B7 (0.60) | UGT2B7SLC6A2SLC6A4SLC6A3KCNH2 | |
| SCHEMBL17064763 | 0.84 | UGT2B7 (0.53) | UGT2B7SLC6A2SLC6A4SLC6A3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8563786-B2 | Method for producing optically active alcohol | MITSUI CHEMICALS, INC. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-04-12 | — | — | US | disclosed |
| EP-2412694-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | Mitsui Chemicals, Inc. (JP) | 2012-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | ADH1A, ADH1C, FHIT | UGT2B7 169/4885SLC6A2 3969/4885SLC6A4 2886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.